Analyst Consensus ?
ConsensusHold34 ratings
Bullish1132.4%
Neutral2264.7%
Bearish12.9%
FN2 Earnings Intelligence
Marsh & McLennan Companies, Inc. analyst ratings
Marsh & McLennan Companies, Inc. (MRSH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$194.72Previous close
$135Low
$202.19Average
$256High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Oct 20, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 19, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 19, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 16, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 16, 2026 |
| UBS | Buy | Buy | Maintain | Oct 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 6, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 10, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | May 26, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Apr 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 8, 2026 |
| Raymond James | Strong Buy | Outperform | Upgrade | Feb 17, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2026 |
| TD Cowen | Hold | Hold | Maintain | Nov 3, 2025 |
| Goldman Sachs | Neutral | Sell | Upgrade | Oct 20, 2025 |
| Jefferies | Hold | Hold | Maintain | Oct 5, 2023 |
| BMO Capital | Market Perform | Market Perform | Maintain | May 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 29, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 7, 2022 |
| MKM Partners | Neutral | Neutral | Maintain | Apr 30, 2020 |
| CFRA | Buy | Hold | Upgrade | Apr 29, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jun 12, 2019 |
| Compass Point | Neutral | Neutral | Maintain | Jan 15, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 26, 2018 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 3, 2017 |
| Sandler O'Neill | Buy | Hold | Upgrade | Nov 7, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 4, 2015 |
| Keefe, Bruyette& Woods | Market Perform | Market Perform | Maintain | Feb 8, 2015 |
| Macquarie | Neutral | Outperform | Downgrade | Sep 24, 2014 |
| Evercore Partners | Overweight | Overweight | Maintain | Jul 9, 2014 |
| Nomura | Neutral | Neutral | Maintain | Mar 11, 2014 |
| Miller Tabak | Hold | Buy | Downgrade | Oct 3, 2013 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $194.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $200 | $188.35 | +2.7% | Oct 19, 2026 |
| Wells Fargo | Analyst unavailable | $197 | $186.54 | +1.2% | Oct 16, 2026 |
| Mizuho Securities | Analyst unavailable | $190 | $171.75 | -2.4% | Oct 7, 2026 |
| UBS | Analyst unavailable | $222 | $170.43 | +14.0% | Oct 6, 2026 |
| BMO Capital | Analyst unavailable | $203 | $194.67 | +4.3% | Aug 25, 2026 |
| Morgan Stanley | Analyst unavailable | $200 | $186.37 | +2.7% | Aug 19, 2026 |
| UBS | Analyst unavailable | $216 | $184.62 | +10.9% | Jul 27, 2026 |
| Mizuho Securities | Yaron Kinar | $201 | $181.59 | +3.2% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $188 | $181.59 | -3.5% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $182.22 | -7.6% | Jul 21, 2026 |
| Evercore ISI | Analyst unavailable | $234 | $179.91 | +20.2% | Jul 10, 2026 |
| Mizuho Securities | Analyst unavailable | $197 | $179.05 | +1.2% | Jul 9, 2026 |
| UBS | Analyst unavailable | $212 | $177.18 | +8.9% | Jul 8, 2026 |
| Morgan Stanley | Analyst unavailable | $175 | $178.54 | -10.1% | Jul 6, 2026 |
| UBS | Brian Meredith | $203 | $162.52 | +4.3% | Jun 9, 2026 |
| Piper Sandler | Analyst unavailable | $182 | $164.11 | -6.5% | May 26, 2026 |
| UBS | Analyst unavailable | $180 | $163.38 | -7.6% | May 21, 2026 |
| Mizuho Securities | Analyst unavailable | $193 | $171.93 | -0.9% | Apr 13, 2026 |
| Raymond James | Strong Buy | $225 | $174.06 | +15.6% | Feb 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $212 | $190.46 | +8.9% | Feb 2, 2026 |
| Mizuho Securities | Analyst unavailable | $213 | $188.19 | +9.4% | Feb 2, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $208 | $182.7 | +6.8% | Jan 14, 2026 |
| Wells Fargo | Elyse Greenspan | $199 | $185.63 | +2.2% | Jan 13, 2026 |
| Barclays | Alex Scott | $210 | $182.9 | +7.8% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $199 | $182.9 | +2.2% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $236 | $182.65 | +21.2% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $190 | $187.28 | -2.4% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $212 | $187.28 | +8.9% | Dec 15, 2025 |
| RBC Capital | Analyst unavailable | $200 | $179.28 | +2.7% | Nov 24, 2025 |
| Barclays | Alex Scott | $206 | $177.13 | +5.8% | Nov 20, 2025 |
| Roth Capital | Harry Fong | $200 | $189.59 | +2.7% | Oct 20, 2025 |
| Goldman Sachs | Analyst unavailable | $195 | $189.59 | +0.1% | Oct 20, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $189.16 | +0.1% | Oct 17, 2025 |
| Evercore ISI | Analyst unavailable | $237 | $189.8 | +21.7% | Oct 17, 2025 |
| Wells Fargo | Elyse Greenspan | $212 | $186.48 | +8.9% | Oct 17, 2025 |
| UBS | Analyst unavailable | $257 | $203.84 | +32.0% | Oct 8, 2025 |
| Barclays | Alex Scott | $221 | $203.84 | +13.5% | Oct 8, 2025 |
| Morgan Stanley | Bob Huang | $215 | $203.2 | +10.4% | Oct 7, 2025 |
| Morgan Stanley | Bob Huang | $220 | $207.74 | +13.0% | Aug 18, 2025 |
| Cantor Fitzgerald | Ryan Tunis | $256 | $204.41 | +31.5% | Aug 12, 2025 |
| UBS | Brian Meredith | $258 | $212.86 | +32.5% | Jul 21, 2025 |
| BMO Capital | Michael Zaremski | $228 | $222.06 | +17.1% | Oct 22, 2024 |
| Roth Capital | Harry Fong | $230 | $225.88 | +18.1% | Oct 18, 2024 |
| RBC Capital | Mark Dwelle | $242 | $226.92 | +24.3% | Oct 18, 2024 |
| Goldman Sachs | Robert Cox | $220 | $226.92 | +13.0% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $250 | $226.76 | +28.4% | Oct 10, 2024 |
| BMO Capital | Michael Zaremski | $217 | $224.01 | +11.4% | Oct 1, 2024 |
| Barclays | Alex Scott | $236 | $231.42 | +21.2% | Sep 4, 2024 |
| Roth Capital | Harry Fong | $220 | $217.42 | +13.0% | Jul 19, 2024 |
| RBC Capital | Mark Dwelle | $228 | $210.94 | +17.1% | Jun 28, 2024 |
| RBC Capital | Mark Dwelle | $210 | $201.73 | +7.8% | Apr 19, 2024 |
| Wells Fargo | Elyse Greenspan | $213 | $201.73 | +9.4% | Apr 19, 2024 |
| Evercore ISI | David Motemaden | $221 | $201.73 | +13.5% | Apr 18, 2024 |
| Piper Sandler | Paul Newsome | $211 | $196.29 | +8.4% | Apr 17, 2024 |
| Citigroup | Analyst unavailable | $190 | $175.28 | -2.4% | Feb 1, 2023 |
| Jefferies | Analyst unavailable | $178 | $170.96 | -8.6% | Jan 9, 2023 |
| Credit Suisse | Andrew Kligerman | $157 | $165.7 | -19.4% | Dec 23, 2022 |
| Citigroup | Analyst unavailable | $185 | $168.57 | -5.0% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $150 | $169.58 | -23.0% | Nov 22, 2022 |
| Atlantic Equities | John Heagerty | $185 | $163.01 | -5.0% | Nov 8, 2022 |
| Raymond James | Analyst unavailable | $180 | $158.12 | -7.6% | Jul 22, 2022 |
| Jefferies | Analyst unavailable | $181 | $155.95 | -7.0% | Jul 12, 2022 |
| Morgan Stanley | Analyst unavailable | $163 | $149.77 | -16.3% | May 23, 2022 |
| Wells Fargo | Analyst unavailable | $183 | $157.93 | -6.0% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $164 | $175.32 | -15.8% | Apr 22, 2022 |
| Piper Sandler | Analyst unavailable | $197 | $175.76 | +1.2% | Apr 22, 2022 |
| Raymond James | Analyst unavailable | $190 | $178.7 | -2.4% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $185 | $178.7 | -5.0% | Apr 22, 2022 |
| J.P. Morgan | Analyst unavailable | $163 | $179.6 | -16.3% | Apr 21, 2022 |
| Piper Sandler | Paul Newsome | $145 | $132.19 | -25.5% | Apr 28, 2021 |
| Deutsche Bank | Phil Stefano | $135 | $132.19 | -30.7% | Apr 28, 2021 |
Track every rating change on MRSH the moment it posts. Free to start.
Start freeGet the MRSH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.